Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-3145 | chia-screen-data-Fav | 2.226 | 2.10e-07 | 3.98e-02 | 3.04e-02 | 23 | 17 |
int-snw-6334 | chia-screen-data-Fav | 2.813 | 2.82e-15 | 6.25e-04 | 4.06e-03 | 16 | 14 |
reg-snw-8562 | chia-screen-data-Fav | 2.263 | 1.35e-07 | 3.15e-02 | 2.44e-02 | 32 | 24 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Transcription factor | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|---|
ANAPC5 | 51433 | 6 | -1.264 | 2.263 | 239 | TF | - | - |
CNOT1 | 23019 | 7 | -2.347 | 2.263 | 124 | - | Yes | - |
PHB2 | 11331 | 6 | -2.236 | 2.994 | 151 | - | Yes | - |
SCN8A | 6334 | 3 | -1.173 | 2.813 | 5 | - | - | - |
PHB | 5245 | 12 | -2.743 | 2.689 | 163 | - | Yes | Yes |
REXO4 | 57109 | 3 | -1.743 | 2.287 | 95 | TF | - | - |
MED28 | 80306 | 6 | -2.404 | 2.445 | 86 | - | Yes | - |
ICT1 | 3396 | 3 | -2.210 | 2.813 | 208 | - | Yes | - |
TIA1 | 7072 | 4 | -1.234 | 2.263 | 53 | TF | - | - |
CBLL1 | 79872 | 6 | -1.897 | 2.445 | 38 | TF | - | - |
MED13L | 23389 | 8 | -2.550 | 2.307 | 50 | - | Yes | - |
VARS | 7407 | 8 | -2.366 | 2.689 | 204 | TF | Yes | - |
APC | 324 | 6 | -2.293 | 3.004 | 384 | TF | Yes | - |
POU5F1 | 5460 | 12 | -5.148 | 3.538 | 179 | - | Yes | Yes |
GSTP1 | 2950 | 3 | -2.251 | 2.955 | 59 | - | Yes | - |
MAPK14 | 1432 | 3 | -1.902 | 2.955 | 304 | - | - | - |
FBXO22 | 26263 | 8 | -1.739 | 2.459 | 208 | TF | - | - |
DENR | 8562 | 4 | -1.023 | 2.263 | 42 | - | - | - |
PSMD2 | 5708 | 6 | -4.172 | 3.157 | 389 | - | Yes | Yes |
FOXJ3 | 22887 | 4 | -2.407 | 2.369 | 87 | TF | Yes | Yes |
EIF2S2 | 8894 | 9 | -2.999 | 2.459 | 103 | - | Yes | Yes |
FBXL6 | 26233 | 5 | -2.253 | 2.689 | 22 | - | Yes | - |
SUV39H2 | 79723 | 7 | -2.307 | 2.410 | 21 | - | Yes | Yes |
COPS3 | 8533 | 5 | -1.873 | 2.435 | 118 | TF | - | - |
CASP2 | 835 | 4 | -2.007 | 2.445 | 47 | TF | Yes | - |
ETF1 | 2107 | 7 | -2.829 | 2.503 | 77 | - | Yes | Yes |
GTF3C3 | 9330 | 4 | -1.450 | 2.428 | 62 | TF | - | - |
CLPP | 8192 | 3 | -2.200 | 2.291 | 10 | - | Yes | - |
CCT7 | 10574 | 10 | -2.335 | 2.459 | 173 | - | Yes | - |
CPSF3 | 51692 | 7 | -2.686 | 2.503 | 31 | - | Yes | Yes |
HNRNPU | 3192 | 12 | -2.869 | 2.644 | 172 | - | Yes | - |
ZNRD1 | 30834 | 3 | -1.375 | 2.226 | 106 | TF | - | - |
CLASP1 | 23332 | 4 | -2.365 | 2.459 | 39 | TF | Yes | - |
TMEM14B | 81853 | 3 | -2.879 | 2.226 | 6 | - | Yes | Yes |
NDUFA4L2 | 56901 | 10 | -2.477 | 2.459 | 21 | - | Yes | - |
CENPA | 1058 | 5 | -2.185 | 2.393 | 205 | TF | Yes | - |
AGPS | 8540 | 6 | -2.424 | 2.410 | 27 | - | Yes | Yes |
SLC7A5P1 | 81893 | 4 | -3.217 | 2.445 | 4 | - | Yes | - |
YAP1 | 10413 | 12 | -4.256 | 3.538 | 53 | - | Yes | - |
NCBP1 | 4686 | 8 | -2.510 | 2.459 | 84 | - | Yes | Yes |
SYNCRIP | 10492 | 8 | -2.401 | 2.503 | 247 | TF | Yes | Yes |
SNAP23 | 8773 | 3 | -2.073 | 2.430 | 15 | - | Yes | - |
ZDHHC20 | 253832 | 4 | -2.673 | 2.326 | 25 | - | Yes | - |
TADA2B | 93624 | 4 | -3.061 | 3.082 | 19 | - | Yes | - |
POLR2E | 5434 | 5 | -2.037 | 2.644 | 316 | TF | Yes | - |
FTSJ1 | 24140 | 5 | -2.463 | 2.689 | 130 | - | Yes | Yes |
EIF2B2 | 8892 | 4 | -2.462 | 2.968 | 95 | - | Yes | Yes |
GSPT1 | 2935 | 7 | -2.313 | 2.503 | 47 | - | Yes | Yes |
HMBS | 3145 | 3 | -1.117 | 2.226 | 22 | - | - | - |
EIF2B3 | 8891 | 5 | -2.546 | 2.435 | 13 | - | Yes | Yes |
COPS6 | 10980 | 3 | -1.765 | 2.393 | 157 | TF | - | - |
GPS1 | 2873 | 10 | -3.621 | 2.689 | 62 | TF | Yes | Yes |
NOLC1 | 9221 | 5 | -1.985 | 2.503 | 136 | TF | - | - |
POLH | 5429 | 8 | -2.586 | 2.459 | 24 | - | Yes | Yes |
BTRC | 8945 | 4 | -1.144 | 2.263 | 64 | TF | - | - |
DDIT3 | 1649 | 11 | -2.825 | 3.504 | 343 | - | Yes | Yes |
FUBP1 | 8880 | 6 | -2.414 | 2.389 | 41 | TF | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
CENPA | 1058 | ZNRD1 | 30834 | pd | <> | reg.ITFP.txt: no annot |
CCT7 | 10574 | REXO4 | 57109 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | DDIT3 | 1649 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vitro |
DENR | 8562 | CBLL1 | 79872 | pd | < | reg.ITFP.txt: no annot |
BTRC | 8945 | FOXJ3 | 22887 | pd | <> | reg.ITFP.txt: no annot |
ETF1 | 2107 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
NCBP1 | 4686 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
PHB | 5245 | VARS | 7407 | pd | < | reg.ITFP.txt: no annot |
CCT7 | 10574 | ZNRD1 | 30834 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | GSTP1 | 2950 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BCI |
TIA1 | 7072 | CLASP1 | 23332 | pd | <> | reg.ITFP.txt: no annot |
GPS1 | 2873 | PHB | 5245 | pd | > | reg.ITFP.txt: no annot |
APC | 324 | CCT7 | 10574 | pp | -- | int.I2D: Jorgensen_EphR, SOURAV_MAPK_LOW, IntAct |
EIF2B2 | 8892 | TADA2B | 93624 | pp | -- | int.I2D: BioGrid_Fly, BIND_Fly, FlyLow, IntAct_Fly, MINT_Fly |
APC | 324 | PHB | 5245 | pp | -- | int.I2D: Jorgensen_EphR |
ETF1 | 2107 | GSPT1 | 2935 | pp | -- | int.I2D: MINT, BCI, BioGrid, HPRD; int.Mint: MI:0915(physical association); int.HPRD: in vivo, yeast 2-hybrid |
ICT1 | 3396 | PHB | 5245 | pp | -- | int.I2D: BioGrid |
POLR2E | 5434 | ANAPC5 | 51433 | pd | <> | reg.ITFP.txt: no annot |
HNRNPU | 3192 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
COPS3 | 8533 | COPS6 | 10980 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BIND, HPRD, IntAct, BCI, INNATEDB, MGI; int.HPRD: in vitro; int.DIP: MI:0915(physical association) |
PSMD2 | 5708 | CNOT1 | 23019 | pp | -- | int.I2D: YeastLow |
DENR | 8562 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
CNOT1 | 23019 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
POLH | 5429 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
POLR2E | 5434 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
MAPK14 | 1432 | BTRC | 8945 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | BTRC | 8945 | pp | -- | int.I2D: BioGrid |
GSPT1 | 2935 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
GPS1 | 2873 | COPS6 | 10980 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid, HPRD, MGI; int.HPRD: in vitro |
DENR | 8562 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
HMBS | 3145 | COPS3 | 8533 | pd | < | reg.ITFP.txt: no annot |
CENPA | 1058 | SUV39H2 | 79723 | pd | > | reg.ITFP.txt: no annot |
NCBP1 | 4686 | CBLL1 | 79872 | pd | < | reg.ITFP.txt: no annot |
POLR2E | 5434 | FTSJ1 | 24140 | pd | > | reg.ITFP.txt: no annot |
CCT7 | 10574 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
DENR | 8562 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
DENR | 8562 | GTF3C3 | 9330 | pd | < | reg.ITFP.txt: no annot |
CBLL1 | 79872 | MED28 | 80306 | pd | > | reg.ITFP.txt: no annot |
POLR2E | 5434 | SNAP23 | 8773 | pd | > | reg.ITFP.txt: no annot |
PHB | 5245 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, IntAct_Yeast |
VARS | 7407 | FTSJ1 | 24140 | pd | > | reg.ITFP.txt: no annot |
CENPA | 1058 | FBXL6 | 26233 | pd | > | reg.ITFP.txt: no annot |
HMBS | 3145 | REXO4 | 57109 | pd | < | reg.ITFP.txt: no annot |
HMBS | 3145 | ZNRD1 | 30834 | pd | < | reg.ITFP.txt: no annot |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CENPA | 1058 | HMBS | 3145 | pd | > | reg.ITFP.txt: no annot |
HMBS | 3145 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
PHB2 | 11331 | ZNRD1 | 30834 | pd | < | reg.ITFP.txt: no annot |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HNRNPU | 3192 | BTRC | 8945 | pp | -- | int.I2D: BCI, BioGrid, INNATEDB, HPRD; int.HPRD: in vivo |
PSMD2 | 5708 | VARS | 7407 | pp | -- | int.I2D: BioGrid_Yeast |
BTRC | 8945 | ZDHHC20 | 253832 | pd | > | reg.ITFP.txt: no annot |
GPS1 | 2873 | CLPP | 8192 | pd | > | reg.ITFP.txt: no annot |
VARS | 7407 | FBXL6 | 26233 | pd | > | reg.ITFP.txt: no annot |
MAPK14 | 1432 | EIF2B2 | 8892 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
APC | 324 | FOXJ3 | 22887 | pd | <> | reg.ITFP.txt: no annot |
MAPK14 | 1432 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
DDIT3 | 1649 | VARS | 7407 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
MAPK14 | 1432 | FUBP1 | 8880 | pp | -- | int.I2D: BioGrid |
AGPS | 8540 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
GPS1 | 2873 | COPS3 | 8533 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, IntAct, INNATEDB, BioGrid, MGI; int.HPRD: in vitro, yeast 2-hybrid |
MED13L | 23389 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
EIF2B3 | 8891 | EIF2S2 | 8894 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro |
CASP2 | 835 | DENR | 8562 | pd | > | reg.ITFP.txt: no annot |
ZNRD1 | 30834 | TMEM14B | 81853 | pd | > | reg.ITFP.txt: no annot |
ETF1 | 2107 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
YAP1 | 10413 | MED28 | 80306 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
PHB | 5245 | ZNRD1 | 30834 | pd | < | reg.ITFP.txt: no annot |
BTRC | 8945 | CNOT1 | 23019 | pd | > | reg.ITFP.txt: no annot |
PSMD2 | 5708 | CCT7 | 10574 | pp | -- | int.I2D: BioGrid_Yeast |
PHB2 | 11331 | FTSJ1 | 24140 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
COPS3 | 8533 | EIF2B3 | 8891 | pd | > | reg.ITFP.txt: no annot |
HMBS | 3145 | COPS6 | 10980 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | POLR2E | 5434 | pd | < | reg.ITFP.txt: no annot |
DENR | 8562 | NOLC1 | 9221 | pd | < | reg.ITFP.txt: no annot |
EIF2B2 | 8892 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh |
SYNCRIP | 10492 | CPSF3 | 51692 | pd | > | reg.ITFP.txt: no annot |
EIF2S2 | 8894 | GTF3C3 | 9330 | pd | < | reg.ITFP.txt: no annot |
SYNCRIP | 10492 | SUV39H2 | 79723 | pd | > | reg.ITFP.txt: no annot |
MED13L | 23389 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
CENPA | 1058 | NDUFA4L2 | 56901 | pd | > | reg.ITFP.txt: no annot |
PSMD2 | 5708 | EIF2B2 | 8892 | pp | -- | int.I2D: IntAct_Yeast |
TIA1 | 7072 | DENR | 8562 | pd | > | reg.ITFP.txt: no annot |
DDIT3 | 1649 | GSTP1 | 2950 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CASP2 | 835 | SLC7A5P1 | 81893 | pd | > | reg.ITFP.txt: no annot |
GPS1 | 2873 | PHB2 | 11331 | pd | > | reg.ITFP.txt: no annot |
COPS6 | 10980 | FBXO22 | 26263 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, IntAct |
CASP2 | 835 | CBLL1 | 79872 | pd | <> | reg.ITFP.txt: no annot |
SNAP23 | 8773 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
NOLC1 | 9221 | FTSJ1 | 24140 | pd | > | reg.ITFP.txt: no annot |
APC | 324 | BTRC | 8945 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, IntAct, INNATEDB |
GSPT1 | 2935 | NOLC1 | 9221 | pd | < | reg.ITFP.txt: no annot |
VARS | 7407 | FBXO22 | 26263 | pd | <> | reg.ITFP.txt: no annot |
PHB | 5245 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
HNRNPU | 3192 | SYNCRIP | 10492 | pp | -- | int.Mint: MI:0915(physical association) |
MAPK14 | 1432 | SCN8A | 6334 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
ICT1 | 3396 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid |
FBXO22 | 26263 | NDUFA4L2 | 56901 | pd | > | reg.ITFP.txt: no annot |
PHB | 5245 | SCN8A | 6334 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
APC | 324 | SYNCRIP | 10492 | pp | -- | int.I2D: Jorgensen_EphR |
HNRNPU | 3192 | POLR2E | 5434 | pd | < | reg.ITFP.txt: no annot |
POLR2E | 5434 | VARS | 7407 | pd | <> | reg.ITFP.txt: no annot |
FUBP1 | 8880 | ANAPC5 | 51433 | pd | <> | reg.ITFP.txt: no annot |
EIF2S2 | 8894 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
CLPP | 8192 | COPS6 | 10980 | pd | < | reg.ITFP.txt: no annot |
DENR | 8562 | BTRC | 8945 | pd | < | reg.ITFP.txt: no annot |
BTRC | 8945 | YAP1 | 10413 | pp | -- | int.I2D: BioGrid, MINT; int.Mint: MI:0915(physical association) |
PSMD2 | 5708 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0010467 | gene expression | 4.96e-08 | 8.09e-04 | 2.583 | 14 | 27 | 669 |
GO:0005515 | protein binding | 2.15e-06 | 3.52e-02 | 0.866 | 39 | 77 | 6127 |
GO:0010388 | cullin deneddylation | 3.34e-06 | 5.46e-02 | 6.577 | 3 | 5 | 9 |
GO:0005654 | nucleoplasm | 3.47e-06 | 5.67e-02 | 1.972 | 15 | 31 | 1095 |
GO:0005829 | cytosol | 2.40e-05 | 3.91e-01 | 1.298 | 22 | 38 | 2562 |
GO:0003743 | translation initiation factor activity | 2.52e-05 | 4.11e-01 | 4.547 | 4 | 5 | 49 |
GO:0051716 | cellular response to stimulus | 7.16e-05 | 1.00e+00 | 7.162 | 2 | 2 | 4 |
GO:0003747 | translation release factor activity | 7.16e-05 | 1.00e+00 | 7.162 | 2 | 2 | 4 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.19e-04 | 1.00e+00 | 6.840 | 2 | 2 | 5 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.78e-04 | 1.00e+00 | 6.577 | 2 | 2 | 6 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 1.78e-04 | 1.00e+00 | 6.577 | 2 | 3 | 6 |
GO:0008180 | COP9 signalosome | 2.24e-04 | 1.00e+00 | 4.659 | 3 | 6 | 34 |
GO:0000398 | mRNA splicing, via spliceosome | 2.72e-04 | 1.00e+00 | 3.117 | 5 | 9 | 165 |
GO:0044822 | poly(A) RNA binding | 2.87e-04 | 1.00e+00 | 1.672 | 12 | 27 | 1078 |
GO:0006379 | mRNA cleavage | 5.30e-04 | 1.00e+00 | 5.840 | 2 | 2 | 10 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 5.30e-04 | 1.00e+00 | 5.840 | 2 | 2 | 10 |
GO:0051010 | microtubule plus-end binding | 6.46e-04 | 1.00e+00 | 5.702 | 2 | 2 | 11 |
GO:0001054 | RNA polymerase I activity | 6.46e-04 | 1.00e+00 | 5.702 | 2 | 2 | 11 |
GO:0030529 | ribonucleoprotein complex | 6.71e-04 | 1.00e+00 | 3.329 | 4 | 6 | 114 |
GO:0005736 | DNA-directed RNA polymerase I complex | 7.73e-04 | 1.00e+00 | 5.577 | 2 | 2 | 12 |
GO:0008143 | poly(A) binding | 7.73e-04 | 1.00e+00 | 5.577 | 2 | 2 | 12 |
GO:0005739 | mitochondrion | 8.59e-04 | 1.00e+00 | 1.590 | 11 | 16 | 1046 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 9.12e-04 | 1.00e+00 | 5.461 | 2 | 2 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 9.12e-04 | 1.00e+00 | 5.461 | 2 | 2 | 13 |
GO:0016071 | mRNA metabolic process | 1.07e-03 | 1.00e+00 | 2.683 | 5 | 8 | 223 |
GO:0006479 | protein methylation | 1.22e-03 | 1.00e+00 | 5.255 | 2 | 2 | 15 |
GO:0008380 | RNA splicing | 1.28e-03 | 1.00e+00 | 2.625 | 5 | 14 | 232 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.39e-03 | 1.00e+00 | 5.162 | 2 | 2 | 16 |
GO:0003723 | RNA binding | 1.45e-03 | 1.00e+00 | 2.275 | 6 | 15 | 355 |
GO:0016070 | RNA metabolic process | 1.68e-03 | 1.00e+00 | 2.535 | 5 | 8 | 247 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.87e-03 | 1.00e+00 | 3.617 | 3 | 4 | 70 |
GO:0014003 | oligodendrocyte development | 2.19e-03 | 1.00e+00 | 4.840 | 2 | 3 | 20 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.20e-03 | 1.00e+00 | 3.537 | 3 | 4 | 74 |
GO:0016032 | viral process | 2.63e-03 | 1.00e+00 | 1.892 | 7 | 16 | 540 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.65e-03 | 1.00e+00 | 3.443 | 3 | 4 | 79 |
GO:0044212 | transcription regulatory region DNA binding | 2.98e-03 | 1.00e+00 | 2.744 | 4 | 5 | 171 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.15e-03 | 1.00e+00 | 4.577 | 2 | 2 | 24 |
GO:0070126 | mitochondrial translational termination | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0097057 | TRAF2-GSTP1 complex | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0031592 | centrosomal corona | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0097165 | nuclear stress granule | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0016150 | translation release factor activity, codon nonspecific | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0004418 | hydroxymethylbilane synthase activity | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0070664 | negative regulation of leukocyte proliferation | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0035732 | nitric oxide storage | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0070026 | nitric oxide binding | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0035731 | dinitrosyl-iron complex binding | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0018160 | peptidyl-pyrromethane cofactor linkage | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0038066 | p38MAPK cascade | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0035730 | S-nitrosoglutathione binding | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 1 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.56e-03 | 1.00e+00 | 2.015 | 6 | 14 | 425 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 3.59e-03 | 1.00e+00 | 3.287 | 3 | 4 | 88 |
GO:0031047 | gene silencing by RNA | 3.69e-03 | 1.00e+00 | 4.461 | 2 | 2 | 26 |
GO:0030331 | estrogen receptor binding | 3.98e-03 | 1.00e+00 | 4.407 | 2 | 2 | 27 |
GO:0001649 | osteoblast differentiation | 4.45e-03 | 1.00e+00 | 3.177 | 3 | 3 | 95 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.90e-03 | 1.00e+00 | 4.255 | 2 | 2 | 30 |
GO:0007094 | mitotic spindle assembly checkpoint | 5.22e-03 | 1.00e+00 | 4.207 | 2 | 3 | 31 |
GO:0016592 | mediator complex | 6.62e-03 | 1.00e+00 | 4.032 | 2 | 5 | 35 |
GO:0060242 | contact inhibition | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0000939 | condensed chromosome inner kinetochore | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0045309 | protein phosphorylated amino acid binding | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0060965 | negative regulation of gene silencing by miRNA | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0030981 | cortical microtubule cytoskeleton | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0004832 | valine-tRNA ligase activity | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0009368 | endopeptidase Clp complex | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0009890 | negative regulation of biosynthetic process | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0008175 | tRNA methyltransferase activity | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0006438 | valyl-tRNA aminoacylation | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0019207 | kinase regulator activity | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0001554 | luteolysis | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0051294 | establishment of spindle orientation | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0009798 | axis specification | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 2 |
GO:0006446 | regulation of translational initiation | 7.00e-03 | 1.00e+00 | 3.992 | 2 | 2 | 36 |
GO:0042552 | myelination | 7.00e-03 | 1.00e+00 | 3.992 | 2 | 2 | 36 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.38e-03 | 1.00e+00 | 2.914 | 3 | 3 | 114 |
GO:0044267 | cellular protein metabolic process | 7.41e-03 | 1.00e+00 | 1.795 | 6 | 7 | 495 |
GO:0000209 | protein polyubiquitination | 7.75e-03 | 1.00e+00 | 2.889 | 3 | 5 | 116 |
GO:0006383 | transcription from RNA polymerase III promoter | 8.17e-03 | 1.00e+00 | 3.876 | 2 | 3 | 39 |
GO:0009408 | response to heat | 8.58e-03 | 1.00e+00 | 3.840 | 2 | 2 | 40 |
GO:0035019 | somatic stem cell maintenance | 8.58e-03 | 1.00e+00 | 3.840 | 2 | 2 | 40 |
GO:0005881 | cytoplasmic microtubule | 9.00e-03 | 1.00e+00 | 3.804 | 2 | 2 | 41 |
GO:0017148 | negative regulation of translation | 9.00e-03 | 1.00e+00 | 3.804 | 2 | 3 | 41 |
GO:0006412 | translation | 9.12e-03 | 1.00e+00 | 2.285 | 4 | 5 | 235 |
GO:0031124 | mRNA 3'-end processing | 9.43e-03 | 1.00e+00 | 3.769 | 2 | 4 | 42 |
GO:0050434 | positive regulation of viral transcription | 1.03e-02 | 1.00e+00 | 3.702 | 2 | 2 | 44 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 3 |
GO:0016149 | translation release factor activity, codon specific | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 3 |
GO:0004045 | aminoacyl-tRNA hydrolase activity | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 3 |
GO:0035726 | common myeloid progenitor cell proliferation | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 2 | 3 |
GO:0090400 | stress-induced premature senescence | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 3 |
GO:0006369 | termination of RNA polymerase II transcription | 1.08e-02 | 1.00e+00 | 3.670 | 2 | 4 | 45 |
GO:0006413 | translational initiation | 1.08e-02 | 1.00e+00 | 2.713 | 3 | 4 | 131 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.12e-02 | 1.00e+00 | 3.638 | 2 | 2 | 46 |
GO:0043434 | response to peptide hormone | 1.12e-02 | 1.00e+00 | 3.638 | 2 | 2 | 46 |
GO:0048511 | rhythmic process | 1.17e-02 | 1.00e+00 | 3.607 | 2 | 2 | 47 |
GO:0004842 | ubiquitin-protein transferase activity | 1.22e-02 | 1.00e+00 | 2.162 | 4 | 5 | 256 |
GO:0000278 | mitotic cell cycle | 1.25e-02 | 1.00e+00 | 1.847 | 5 | 12 | 398 |
GO:0005778 | peroxisomal membrane | 1.32e-02 | 1.00e+00 | 3.518 | 2 | 2 | 50 |
GO:0000778 | condensed nuclear chromosome kinetochore | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 2 | 4 |
GO:0060913 | cardiac cell fate determination | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0046523 | S-methyl-5-thioribose-1-phosphate isomerase activity | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0019887 | protein kinase regulator activity | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0008611 | ether lipid biosynthetic process | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0043515 | kinetochore binding | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0002192 | IRES-dependent translational initiation | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 4 |
GO:0000775 | chromosome, centromeric region | 1.42e-02 | 1.00e+00 | 3.461 | 2 | 3 | 52 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.60e-02 | 1.00e+00 | 1.756 | 5 | 7 | 424 |
GO:0070461 | SAGA-type complex | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 2 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0048742 | regulation of skeletal muscle fiber development | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0001714 | endodermal cell fate specification | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0003407 | neural retina development | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0005828 | kinetochore microtubule | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0051525 | NFAT protein binding | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0006449 | regulation of translational termination | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0036124 | histone H3-K9 trimethylation | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 5 |
GO:0006974 | cellular response to DNA damage stimulus | 1.78e-02 | 1.00e+00 | 2.443 | 3 | 4 | 158 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.81e-02 | 1.00e+00 | 3.279 | 2 | 2 | 59 |
GO:0006396 | RNA processing | 1.86e-02 | 1.00e+00 | 3.255 | 2 | 4 | 60 |
GO:0008013 | beta-catenin binding | 1.86e-02 | 1.00e+00 | 3.255 | 2 | 4 | 60 |
GO:0006406 | mRNA export from nucleus | 1.98e-02 | 1.00e+00 | 3.207 | 2 | 5 | 62 |
GO:0000776 | kinetochore | 2.04e-02 | 1.00e+00 | 3.184 | 2 | 4 | 63 |
GO:0030858 | positive regulation of epithelial cell differentiation | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 2 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0032691 | negative regulation of interleukin-1 beta production | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 2 | 6 |
GO:0006333 | chromatin assembly or disassembly | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0002181 | cytoplasmic translation | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0060744 | mammary gland branching involved in thelarche | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0000127 | transcription factor TFIIIC complex | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 2 | 6 |
GO:0008432 | JUN kinase binding | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 6 |
GO:0009749 | response to glucose | 2.10e-02 | 1.00e+00 | 3.162 | 2 | 2 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.17e-02 | 1.00e+00 | 3.139 | 2 | 3 | 65 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.17e-02 | 1.00e+00 | 3.139 | 2 | 3 | 65 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.29e-02 | 1.00e+00 | 3.095 | 2 | 3 | 67 |
GO:0032930 | positive regulation of superoxide anion generation | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0042753 | positive regulation of circadian rhythm | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0004521 | endoribonuclease activity | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0010458 | exit from mitosis | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0002674 | negative regulation of acute inflammatory response | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0032790 | ribosome disassembly | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0002161 | aminoacyl-tRNA editing activity | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0006282 | regulation of DNA repair | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0035234 | ectopic germ cell programmed cell death | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 7 |
GO:0032872 | regulation of stress-activated MAPK cascade | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0042582 | azurophil granule | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0045670 | regulation of osteoclast differentiation | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0042754 | negative regulation of circadian rhythm | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0006903 | vesicle targeting | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 2.76e-02 | 1.00e+00 | 2.952 | 2 | 2 | 74 |
GO:0001055 | RNA polymerase II activity | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0000339 | RNA cap binding | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0010831 | positive regulation of myotube differentiation | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0016779 | nucleotidyltransferase activity | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 8 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 2.90e-02 | 1.00e+00 | 2.914 | 2 | 2 | 76 |
GO:0005634 | nucleus | 2.95e-02 | 1.00e+00 | 0.509 | 24 | 55 | 4828 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0008409 | 5'-3' exonuclease activity | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0033598 | mammary gland epithelial cell proliferation | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0000302 | response to reactive oxygen species | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0019509 | L-methionine biosynthetic process from methylthioadenosine | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0005832 | chaperonin-containing T-complex | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 9 |
GO:0032495 | response to muramyl dipeptide | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 2 | 9 |
GO:0071013 | catalytic step 2 spliceosome | 3.11e-02 | 1.00e+00 | 2.858 | 2 | 3 | 79 |
GO:0071222 | cellular response to lipopolysaccharide | 3.26e-02 | 1.00e+00 | 2.822 | 2 | 2 | 81 |
GO:0002199 | zona pellucida receptor complex | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0045667 | regulation of osteoblast differentiation | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0001518 | voltage-gated sodium channel complex | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0010225 | response to UV-C | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 2 | 10 |
GO:0008610 | lipid biosynthetic process | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0043194 | axon initial segment | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0006450 | regulation of translational fidelity | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0071949 | FAD binding | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0051382 | kinetochore assembly | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0000731 | DNA synthesis involved in DNA repair | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0030877 | beta-catenin destruction complex | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 10 |
GO:0006355 | regulation of transcription, DNA-templated | 3.70e-02 | 1.00e+00 | 1.053 | 8 | 13 | 1104 |
GO:0006415 | translational termination | 3.71e-02 | 1.00e+00 | 2.719 | 2 | 2 | 87 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0031116 | positive regulation of microtubule polymerization | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0004535 | poly(A)-specific ribonuclease activity | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:2000036 | regulation of stem cell maintenance | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0005845 | mRNA cap binding complex | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0045663 | positive regulation of myoblast differentiation | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0019395 | fatty acid oxidation | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0004707 | MAP kinase activity | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0035413 | positive regulation of catenin import into nucleus | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 3.78e-02 | 1.00e+00 | 4.702 | 1 | 1 | 11 |
GO:0034453 | microtubule anchoring | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0061136 | regulation of proteasomal protein catabolic process | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0045295 | gamma-catenin binding | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0042581 | specific granule | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0032886 | regulation of microtubule-based process | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0008334 | histone mRNA metabolic process | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 12 |
GO:0007140 | male meiosis | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0043508 | negative regulation of JUN kinase activity | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0009416 | response to light stimulus | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0030914 | STAGA complex | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0042974 | retinoic acid receptor binding | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0004708 | MAP kinase kinase activity | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0044295 | axonal growth cone | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0035198 | miRNA binding | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 13 |
GO:0030018 | Z disc | 4.60e-02 | 1.00e+00 | 2.547 | 2 | 2 | 98 |
GO:0035371 | microtubule plus-end | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 14 |
GO:0050905 | neuromuscular process | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 14 |
GO:0071480 | cellular response to gamma radiation | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 14 |
GO:0004527 | exonuclease activity | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 14 |
GO:0007020 | microtubule nucleation | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 14 |
GO:0005095 | GTPase inhibitor activity | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 14 |
GO:0045807 | positive regulation of endocytosis | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 14 |
GO:0006915 | apoptotic process | 4.86e-02 | 1.00e+00 | 1.326 | 5 | 8 | 571 |
GO:0007417 | central nervous system development | 4.86e-02 | 1.00e+00 | 2.503 | 2 | 2 | 101 |
GO:0017091 | AU-rich element binding | 5.11e-02 | 1.00e+00 | 4.255 | 1 | 2 | 15 |
GO:0001824 | blastocyst development | 5.11e-02 | 1.00e+00 | 4.255 | 1 | 1 | 15 |
GO:0030014 | CCR4-NOT complex | 5.11e-02 | 1.00e+00 | 4.255 | 1 | 1 | 15 |
GO:0060749 | mammary gland alveolus development | 5.11e-02 | 1.00e+00 | 4.255 | 1 | 1 | 15 |
GO:0042307 | positive regulation of protein import into nucleus | 5.11e-02 | 1.00e+00 | 4.255 | 1 | 2 | 15 |
GO:0005762 | mitochondrial large ribosomal subunit | 5.11e-02 | 1.00e+00 | 4.255 | 1 | 1 | 15 |
GO:0033268 | node of Ranvier | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 1 | 16 |
GO:0000132 | establishment of mitotic spindle orientation | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 1 | 16 |
GO:0001056 | RNA polymerase III activity | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 1 | 16 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 1 | 16 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 2 | 16 |
GO:0005248 | voltage-gated sodium channel activity | 5.45e-02 | 1.00e+00 | 4.162 | 1 | 1 | 16 |
GO:0016409 | palmitoyltransferase activity | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 17 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 17 |
GO:0001829 | trophectodermal cell differentiation | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 2 | 17 |
GO:0005666 | DNA-directed RNA polymerase III complex | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 17 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 17 |
GO:0001731 | formation of translation preinitiation complex | 5.78e-02 | 1.00e+00 | 4.074 | 1 | 1 | 17 |
GO:0031122 | cytoplasmic microtubule organization | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 1 | 18 |
GO:0006778 | porphyrin-containing compound metabolic process | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 2 | 18 |
GO:0006386 | termination of RNA polymerase III transcription | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 1 | 18 |
GO:0019228 | neuronal action potential | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 1 | 18 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 1 | 18 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.43e-02 | 1.00e+00 | 3.914 | 1 | 1 | 19 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 6.43e-02 | 1.00e+00 | 3.914 | 1 | 2 | 19 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 20 |
GO:0018345 | protein palmitoylation | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 20 |
GO:0006783 | heme biosynthetic process | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 20 |
GO:0001578 | microtubule bundle formation | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 20 |
GO:0001502 | cartilage condensation | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 20 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 20 |
GO:0097194 | execution phase of apoptosis | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 20 |
GO:0005680 | anaphase-promoting complex | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 20 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 1 | 21 |
GO:0045648 | positive regulation of erythrocyte differentiation | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 1 | 21 |
GO:0045862 | positive regulation of proteolysis | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 2 | 21 |
GO:0004364 | glutathione transferase activity | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 1 | 21 |
GO:0016575 | histone deacetylation | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 1 | 21 |
GO:0032757 | positive regulation of interleukin-8 production | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 1 | 21 |
GO:0031648 | protein destabilization | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 2 | 21 |
GO:0009954 | proximal/distal pattern formation | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 1 | 21 |
GO:0000281 | mitotic cytokinesis | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 1 | 21 |
GO:0007050 | cell cycle arrest | 7.17e-02 | 1.00e+00 | 2.184 | 2 | 3 | 126 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7.27e-02 | 1.00e+00 | 2.173 | 2 | 3 | 127 |
GO:0030316 | osteoclast differentiation | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 1 | 22 |
GO:0005720 | nuclear heterochromatin | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 1 | 22 |
GO:0006378 | mRNA polyadenylation | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 1 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 2 | 22 |
GO:0030335 | positive regulation of cell migration | 7.57e-02 | 1.00e+00 | 2.139 | 2 | 2 | 130 |
GO:0034660 | ncRNA metabolic process | 7.74e-02 | 1.00e+00 | 3.638 | 1 | 1 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 7.74e-02 | 1.00e+00 | 3.638 | 1 | 1 | 23 |
GO:0071346 | cellular response to interferon-gamma | 7.74e-02 | 1.00e+00 | 3.638 | 1 | 2 | 23 |
GO:1901687 | glutathione derivative biosynthetic process | 7.74e-02 | 1.00e+00 | 3.638 | 1 | 1 | 23 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 7.74e-02 | 1.00e+00 | 3.638 | 1 | 1 | 23 |
GO:0016020 | membrane | 7.86e-02 | 1.00e+00 | 0.714 | 10 | 27 | 1746 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 8.06e-02 | 1.00e+00 | 3.577 | 1 | 1 | 24 |
GO:0007163 | establishment or maintenance of cell polarity | 8.06e-02 | 1.00e+00 | 3.577 | 1 | 1 | 24 |
GO:0048147 | negative regulation of fibroblast proliferation | 8.06e-02 | 1.00e+00 | 3.577 | 1 | 1 | 24 |
GO:0006363 | termination of RNA polymerase I transcription | 8.06e-02 | 1.00e+00 | 3.577 | 1 | 1 | 24 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 8.06e-02 | 1.00e+00 | 3.577 | 1 | 1 | 24 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.28e-02 | 1.00e+00 | 2.064 | 2 | 3 | 137 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 8.38e-02 | 1.00e+00 | 3.518 | 1 | 1 | 25 |
GO:0071479 | cellular response to ionizing radiation | 8.38e-02 | 1.00e+00 | 3.518 | 1 | 1 | 25 |
GO:0086010 | membrane depolarization during action potential | 8.38e-02 | 1.00e+00 | 3.518 | 1 | 1 | 25 |
GO:0030864 | cortical actin cytoskeleton | 8.38e-02 | 1.00e+00 | 3.518 | 1 | 1 | 25 |
GO:0003899 | DNA-directed RNA polymerase activity | 8.38e-02 | 1.00e+00 | 3.518 | 1 | 1 | 25 |
GO:0045296 | cadherin binding | 8.38e-02 | 1.00e+00 | 3.518 | 1 | 1 | 25 |
GO:0016567 | protein ubiquitination | 8.66e-02 | 1.00e+00 | 1.523 | 3 | 5 | 299 |
GO:0070979 | protein K11-linked ubiquitination | 8.70e-02 | 1.00e+00 | 3.461 | 1 | 1 | 26 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 8.70e-02 | 1.00e+00 | 3.461 | 1 | 1 | 26 |
GO:0016055 | Wnt signaling pathway | 8.70e-02 | 1.00e+00 | 2.022 | 2 | 3 | 141 |
GO:0035329 | hippo signaling | 8.70e-02 | 1.00e+00 | 3.461 | 1 | 1 | 26 |
GO:0061025 | membrane fusion | 8.70e-02 | 1.00e+00 | 3.461 | 1 | 1 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 8.70e-02 | 1.00e+00 | 3.461 | 1 | 2 | 26 |
GO:0051149 | positive regulation of muscle cell differentiation | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 1 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 2 | 27 |
GO:0000387 | spliceosomal snRNP assembly | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 1 | 27 |
GO:0007422 | peripheral nervous system development | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 1 | 27 |
GO:0006913 | nucleocytoplasmic transport | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 1 | 27 |
GO:0000188 | inactivation of MAPK activity | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 1 | 27 |
GO:0034080 | CENP-A containing nucleosome assembly | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 2 | 27 |
GO:0007339 | binding of sperm to zona pellucida | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 1 | 27 |
GO:0000077 | DNA damage checkpoint | 9.34e-02 | 1.00e+00 | 3.354 | 1 | 1 | 28 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 9.34e-02 | 1.00e+00 | 3.354 | 1 | 1 | 28 |
GO:0043022 | ribosome binding | 9.34e-02 | 1.00e+00 | 3.354 | 1 | 2 | 28 |
GO:2001235 | positive regulation of apoptotic signaling pathway | 9.34e-02 | 1.00e+00 | 3.354 | 1 | 1 | 28 |
GO:0008017 | microtubule binding | 9.66e-02 | 1.00e+00 | 1.933 | 2 | 4 | 150 |
GO:0019005 | SCF ubiquitin ligase complex | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 29 |
GO:0007628 | adult walking behavior | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 29 |
GO:0071897 | DNA biosynthetic process | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 29 |
GO:0005913 | cell-cell adherens junction | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 29 |
GO:0016485 | protein processing | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 29 |
GO:0006749 | glutathione metabolic process | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 29 |
GO:0003887 | DNA-directed DNA polymerase activity | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 29 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 1 | 29 |
GO:0000082 | G1/S transition of mitotic cell cycle | 9.66e-02 | 1.00e+00 | 1.933 | 2 | 4 | 150 |
GO:0042981 | regulation of apoptotic process | 9.77e-02 | 1.00e+00 | 1.923 | 2 | 3 | 151 |
GO:0006360 | transcription from RNA polymerase I promoter | 9.97e-02 | 1.00e+00 | 3.255 | 1 | 1 | 30 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 9.97e-02 | 1.00e+00 | 3.255 | 1 | 1 | 30 |
GO:0010494 | cytoplasmic stress granule | 9.97e-02 | 1.00e+00 | 3.255 | 1 | 2 | 30 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 31 |
GO:0005782 | peroxisomal matrix | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 31 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 1 | 32 |
GO:0042594 | response to starvation | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 3 | 32 |
GO:0002062 | chondrocyte differentiation | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 1 | 32 |
GO:0009953 | dorsal/ventral pattern formation | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 1 | 32 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 1 | 32 |
GO:0005525 | GTP binding | 1.07e-01 | 1.00e+00 | 1.389 | 3 | 5 | 328 |
GO:0007162 | negative regulation of cell adhesion | 1.09e-01 | 1.00e+00 | 3.117 | 1 | 1 | 33 |
GO:0070830 | tight junction assembly | 1.09e-01 | 1.00e+00 | 3.117 | 1 | 1 | 33 |
GO:0033077 | T cell differentiation in thymus | 1.09e-01 | 1.00e+00 | 3.117 | 1 | 1 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 1.09e-01 | 1.00e+00 | 3.117 | 1 | 3 | 33 |
GO:0003682 | chromatin binding | 1.11e-01 | 1.00e+00 | 1.363 | 3 | 7 | 334 |
GO:0043407 | negative regulation of MAP kinase activity | 1.12e-01 | 1.00e+00 | 3.074 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 1.12e-01 | 1.00e+00 | 3.074 | 1 | 1 | 34 |
GO:0005876 | spindle microtubule | 1.12e-01 | 1.00e+00 | 3.074 | 1 | 1 | 34 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 1.15e-01 | 1.00e+00 | 3.032 | 1 | 1 | 35 |
GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 1.15e-01 | 1.00e+00 | 3.032 | 1 | 1 | 35 |
GO:0001942 | hair follicle development | 1.15e-01 | 1.00e+00 | 3.032 | 1 | 1 | 35 |
GO:0048538 | thymus development | 1.18e-01 | 1.00e+00 | 2.992 | 1 | 1 | 36 |
GO:0009267 | cellular response to starvation | 1.18e-01 | 1.00e+00 | 2.992 | 1 | 1 | 36 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.19e-01 | 1.00e+00 | 0.937 | 5 | 10 | 748 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.22e-01 | 1.00e+00 | 2.952 | 1 | 1 | 37 |
GO:0001541 | ovarian follicle development | 1.22e-01 | 1.00e+00 | 2.952 | 1 | 1 | 37 |
GO:0042752 | regulation of circadian rhythm | 1.22e-01 | 1.00e+00 | 2.952 | 1 | 3 | 37 |
GO:0007049 | cell cycle | 1.27e-01 | 1.00e+00 | 1.694 | 2 | 4 | 177 |
GO:0051781 | positive regulation of cell division | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 1 | 39 |
GO:0071407 | cellular response to organic cyclic compound | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 3 | 39 |
GO:0003714 | transcription corepressor activity | 1.29e-01 | 1.00e+00 | 1.678 | 2 | 5 | 179 |
GO:0005737 | cytoplasm | 1.33e-01 | 1.00e+00 | 0.374 | 18 | 43 | 3976 |
GO:0045785 | positive regulation of cell adhesion | 1.34e-01 | 1.00e+00 | 2.804 | 1 | 1 | 41 |
GO:0007519 | skeletal muscle tissue development | 1.34e-01 | 1.00e+00 | 2.804 | 1 | 2 | 41 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.35e-01 | 1.00e+00 | 1.638 | 2 | 5 | 184 |
GO:0043565 | sequence-specific DNA binding | 1.35e-01 | 1.00e+00 | 1.235 | 3 | 3 | 365 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.37e-01 | 1.00e+00 | 2.769 | 1 | 3 | 42 |
GO:0043547 | positive regulation of GTPase activity | 1.42e-01 | 1.00e+00 | 1.592 | 2 | 2 | 190 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.43e-01 | 1.00e+00 | 2.702 | 1 | 1 | 44 |
GO:0006892 | post-Golgi vesicle-mediated transport | 1.43e-01 | 1.00e+00 | 2.702 | 1 | 1 | 44 |
GO:0015030 | Cajal body | 1.46e-01 | 1.00e+00 | 2.670 | 1 | 1 | 45 |
GO:0016328 | lateral plasma membrane | 1.49e-01 | 1.00e+00 | 2.638 | 1 | 1 | 46 |
GO:0044297 | cell body | 1.49e-01 | 1.00e+00 | 2.638 | 1 | 1 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.49e-01 | 1.00e+00 | 2.638 | 1 | 1 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 1.52e-01 | 1.00e+00 | 2.607 | 1 | 1 | 47 |
GO:0019827 | stem cell maintenance | 1.55e-01 | 1.00e+00 | 2.577 | 1 | 2 | 48 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 1.58e-01 | 1.00e+00 | 2.547 | 1 | 1 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.61e-01 | 1.00e+00 | 2.518 | 1 | 2 | 50 |
GO:0007254 | JNK cascade | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 2 | 51 |
GO:0003684 | damaged DNA binding | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 1 | 51 |
GO:0006986 | response to unfolded protein | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 2 | 51 |
GO:0000902 | cell morphogenesis | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 1 | 51 |
GO:0045732 | positive regulation of protein catabolic process | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 1 | 51 |
GO:0001701 | in utero embryonic development | 1.67e-01 | 1.00e+00 | 1.447 | 2 | 2 | 210 |
GO:0045454 | cell redox homeostasis | 1.67e-01 | 1.00e+00 | 2.461 | 1 | 1 | 52 |
GO:0004197 | cysteine-type endopeptidase activity | 1.67e-01 | 1.00e+00 | 2.461 | 1 | 1 | 52 |
GO:0034976 | response to endoplasmic reticulum stress | 1.67e-01 | 1.00e+00 | 2.461 | 1 | 1 | 52 |
GO:0009611 | response to wounding | 1.69e-01 | 1.00e+00 | 2.434 | 1 | 1 | 53 |
GO:0060041 | retina development in camera-type eye | 1.69e-01 | 1.00e+00 | 2.434 | 1 | 1 | 53 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.69e-01 | 1.00e+00 | 2.434 | 1 | 2 | 53 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.72e-01 | 1.00e+00 | 2.407 | 1 | 1 | 54 |
GO:0051403 | stress-activated MAPK cascade | 1.72e-01 | 1.00e+00 | 2.407 | 1 | 2 | 54 |
GO:0008233 | peptidase activity | 1.75e-01 | 1.00e+00 | 2.380 | 1 | 1 | 55 |
GO:0000226 | microtubule cytoskeleton organization | 1.75e-01 | 1.00e+00 | 2.380 | 1 | 2 | 55 |
GO:0006814 | sodium ion transport | 1.75e-01 | 1.00e+00 | 2.380 | 1 | 1 | 55 |
GO:0000932 | cytoplasmic mRNA processing body | 1.78e-01 | 1.00e+00 | 2.354 | 1 | 2 | 56 |
GO:0000502 | proteasome complex | 1.84e-01 | 1.00e+00 | 2.304 | 1 | 2 | 58 |
GO:0035725 | sodium ion transmembrane transport | 1.84e-01 | 1.00e+00 | 2.304 | 1 | 1 | 58 |
GO:0016874 | ligase activity | 1.84e-01 | 1.00e+00 | 1.354 | 2 | 4 | 224 |
GO:0006351 | transcription, DNA-templated | 1.85e-01 | 1.00e+00 | 0.531 | 8 | 17 | 1585 |
GO:0005622 | intracellular | 1.87e-01 | 1.00e+00 | 1.341 | 2 | 2 | 226 |
GO:0003677 | DNA binding | 1.90e-01 | 1.00e+00 | 0.569 | 7 | 16 | 1351 |
GO:0005524 | ATP binding | 1.91e-01 | 1.00e+00 | 0.566 | 7 | 13 | 1354 |
GO:0032481 | positive regulation of type I interferon production | 1.92e-01 | 1.00e+00 | 2.231 | 1 | 2 | 61 |
GO:0007067 | mitotic nuclear division | 1.93e-01 | 1.00e+00 | 1.310 | 2 | 4 | 231 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 1.95e-01 | 1.00e+00 | 2.207 | 1 | 2 | 62 |
GO:0000151 | ubiquitin ligase complex | 1.98e-01 | 1.00e+00 | 2.184 | 1 | 2 | 63 |
GO:0006417 | regulation of translation | 1.98e-01 | 1.00e+00 | 2.184 | 1 | 1 | 63 |
GO:0019903 | protein phosphatase binding | 1.98e-01 | 1.00e+00 | 2.184 | 1 | 1 | 63 |
GO:0034146 | toll-like receptor 5 signaling pathway | 2.04e-01 | 1.00e+00 | 2.139 | 1 | 2 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 2.04e-01 | 1.00e+00 | 2.139 | 1 | 2 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 2.04e-01 | 1.00e+00 | 2.139 | 1 | 2 | 65 |
GO:0071260 | cellular response to mechanical stimulus | 2.07e-01 | 1.00e+00 | 2.117 | 1 | 1 | 66 |
GO:0009636 | response to toxic substance | 2.07e-01 | 1.00e+00 | 2.117 | 1 | 1 | 66 |
GO:0007409 | axonogenesis | 2.07e-01 | 1.00e+00 | 2.117 | 1 | 1 | 66 |
GO:0008134 | transcription factor binding | 2.12e-01 | 1.00e+00 | 1.219 | 2 | 6 | 246 |
GO:0000777 | condensed chromosome kinetochore | 2.12e-01 | 1.00e+00 | 2.074 | 1 | 1 | 68 |
GO:0006338 | chromatin remodeling | 2.12e-01 | 1.00e+00 | 2.074 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 2.15e-01 | 1.00e+00 | 2.053 | 1 | 2 | 69 |
GO:0018105 | peptidyl-serine phosphorylation | 2.15e-01 | 1.00e+00 | 2.053 | 1 | 1 | 69 |
GO:0006289 | nucleotide-excision repair | 2.15e-01 | 1.00e+00 | 2.053 | 1 | 1 | 69 |
GO:0006887 | exocytosis | 2.15e-01 | 1.00e+00 | 2.053 | 1 | 1 | 69 |
GO:0000786 | nucleosome | 2.18e-01 | 1.00e+00 | 2.032 | 1 | 1 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 2.20e-01 | 1.00e+00 | 2.012 | 1 | 2 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 2.20e-01 | 1.00e+00 | 2.012 | 1 | 2 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 2.23e-01 | 1.00e+00 | 1.992 | 1 | 2 | 72 |
GO:0032587 | ruffle membrane | 2.23e-01 | 1.00e+00 | 1.992 | 1 | 1 | 72 |
GO:0010468 | regulation of gene expression | 2.23e-01 | 1.00e+00 | 1.992 | 1 | 1 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 2.26e-01 | 1.00e+00 | 1.972 | 1 | 2 | 73 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.26e-01 | 1.00e+00 | 1.972 | 1 | 2 | 73 |
GO:0000785 | chromatin | 2.26e-01 | 1.00e+00 | 1.972 | 1 | 2 | 73 |
GO:0042826 | histone deacetylase binding | 2.29e-01 | 1.00e+00 | 1.952 | 1 | 2 | 74 |
GO:0007265 | Ras protein signal transduction | 2.31e-01 | 1.00e+00 | 1.933 | 1 | 2 | 75 |
GO:0005730 | nucleolus | 2.31e-01 | 1.00e+00 | 0.444 | 8 | 28 | 1684 |
GO:0060070 | canonical Wnt signaling pathway | 2.31e-01 | 1.00e+00 | 1.933 | 1 | 2 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 2.34e-01 | 1.00e+00 | 1.914 | 1 | 2 | 76 |
GO:0006281 | DNA repair | 2.35e-01 | 1.00e+00 | 1.117 | 2 | 4 | 264 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.37e-01 | 1.00e+00 | 1.895 | 1 | 2 | 77 |
GO:0008584 | male gonad development | 2.37e-01 | 1.00e+00 | 1.895 | 1 | 1 | 77 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 2.37e-01 | 1.00e+00 | 1.895 | 1 | 2 | 77 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 2.39e-01 | 1.00e+00 | 1.876 | 1 | 2 | 78 |
GO:0001822 | kidney development | 2.42e-01 | 1.00e+00 | 1.858 | 1 | 2 | 79 |
GO:0006334 | nucleosome assembly | 2.42e-01 | 1.00e+00 | 1.858 | 1 | 3 | 79 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.42e-01 | 1.00e+00 | 0.819 | 3 | 6 | 487 |
GO:0042802 | identical protein binding | 2.45e-01 | 1.00e+00 | 0.807 | 3 | 6 | 491 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 2.45e-01 | 1.00e+00 | 1.840 | 1 | 3 | 80 |
GO:0034138 | toll-like receptor 3 signaling pathway | 2.45e-01 | 1.00e+00 | 1.840 | 1 | 2 | 80 |
GO:0000166 | nucleotide binding | 2.46e-01 | 1.00e+00 | 1.074 | 2 | 6 | 272 |
GO:0051301 | cell division | 2.47e-01 | 1.00e+00 | 1.822 | 1 | 2 | 81 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.47e-01 | 1.00e+00 | 1.069 | 2 | 2 | 273 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 2.47e-01 | 1.00e+00 | 1.822 | 1 | 2 | 81 |
GO:0043065 | positive regulation of apoptotic process | 2.48e-01 | 1.00e+00 | 1.064 | 2 | 3 | 274 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.50e-01 | 1.00e+00 | 1.058 | 2 | 4 | 275 |
GO:0007517 | muscle organ development | 2.53e-01 | 1.00e+00 | 1.787 | 1 | 1 | 83 |
GO:0009952 | anterior/posterior pattern specification | 2.55e-01 | 1.00e+00 | 1.769 | 1 | 2 | 84 |
GO:0009653 | anatomical structure morphogenesis | 2.63e-01 | 1.00e+00 | 1.719 | 1 | 1 | 87 |
GO:0019899 | enzyme binding | 2.66e-01 | 1.00e+00 | 0.992 | 2 | 3 | 288 |
GO:0006464 | cellular protein modification process | 2.68e-01 | 1.00e+00 | 1.686 | 1 | 1 | 89 |
GO:0005777 | peroxisome | 2.71e-01 | 1.00e+00 | 1.670 | 1 | 1 | 90 |
GO:0000187 | activation of MAPK activity | 2.71e-01 | 1.00e+00 | 1.670 | 1 | 2 | 90 |
GO:0000922 | spindle pole | 2.73e-01 | 1.00e+00 | 1.654 | 1 | 1 | 91 |
GO:0016337 | single organismal cell-cell adhesion | 2.76e-01 | 1.00e+00 | 1.638 | 1 | 1 | 92 |
GO:0006928 | cellular component movement | 2.76e-01 | 1.00e+00 | 1.638 | 1 | 1 | 92 |
GO:0016363 | nuclear matrix | 2.76e-01 | 1.00e+00 | 1.638 | 1 | 5 | 92 |
GO:0005923 | tight junction | 2.76e-01 | 1.00e+00 | 1.638 | 1 | 1 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.81e-01 | 1.00e+00 | 1.607 | 1 | 2 | 94 |
GO:0005770 | late endosome | 2.81e-01 | 1.00e+00 | 1.607 | 1 | 1 | 94 |
GO:0005743 | mitochondrial inner membrane | 2.82e-01 | 1.00e+00 | 0.933 | 2 | 3 | 300 |
GO:0051082 | unfolded protein binding | 2.83e-01 | 1.00e+00 | 1.592 | 1 | 3 | 95 |
GO:0034142 | toll-like receptor 4 signaling pathway | 2.86e-01 | 1.00e+00 | 1.577 | 1 | 2 | 96 |
GO:0006364 | rRNA processing | 2.86e-01 | 1.00e+00 | 1.577 | 1 | 2 | 96 |
GO:0071456 | cellular response to hypoxia | 2.91e-01 | 1.00e+00 | 1.547 | 1 | 2 | 98 |
GO:0006470 | protein dephosphorylation | 2.93e-01 | 1.00e+00 | 1.532 | 1 | 1 | 99 |
GO:0051726 | regulation of cell cycle | 3.01e-01 | 1.00e+00 | 1.489 | 1 | 4 | 102 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 3.13e-01 | 1.00e+00 | 1.420 | 1 | 1 | 107 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.14e-01 | 1.00e+00 | 0.498 | 4 | 13 | 811 |
GO:0006935 | chemotaxis | 3.16e-01 | 1.00e+00 | 1.407 | 1 | 1 | 108 |
GO:0008270 | zinc ion binding | 3.16e-01 | 1.00e+00 | 0.424 | 5 | 11 | 1067 |
GO:0007411 | axon guidance | 3.17e-01 | 1.00e+00 | 0.808 | 2 | 2 | 327 |
GO:0002224 | toll-like receptor signaling pathway | 3.18e-01 | 1.00e+00 | 1.393 | 1 | 2 | 109 |
GO:0005938 | cell cortex | 3.18e-01 | 1.00e+00 | 1.393 | 1 | 1 | 109 |
GO:0006461 | protein complex assembly | 3.23e-01 | 1.00e+00 | 1.367 | 1 | 2 | 111 |
GO:0007605 | sensory perception of sound | 3.23e-01 | 1.00e+00 | 1.367 | 1 | 1 | 111 |
GO:0034765 | regulation of ion transmembrane transport | 3.27e-01 | 1.00e+00 | 1.341 | 1 | 1 | 113 |
GO:0030308 | negative regulation of cell growth | 3.27e-01 | 1.00e+00 | 1.341 | 1 | 2 | 113 |
GO:0005813 | centrosome | 3.32e-01 | 1.00e+00 | 0.756 | 2 | 4 | 339 |
GO:0097190 | apoptotic signaling pathway | 3.35e-01 | 1.00e+00 | 1.304 | 1 | 1 | 116 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.39e-01 | 1.00e+00 | 0.544 | 3 | 10 | 589 |
GO:0004252 | serine-type endopeptidase activity | 3.42e-01 | 1.00e+00 | 1.267 | 1 | 1 | 119 |
GO:0006006 | glucose metabolic process | 3.42e-01 | 1.00e+00 | 1.267 | 1 | 1 | 119 |
GO:0003676 | nucleic acid binding | 3.48e-01 | 1.00e+00 | 1.231 | 1 | 2 | 122 |
GO:0006325 | chromatin organization | 3.51e-01 | 1.00e+00 | 1.219 | 1 | 3 | 123 |
GO:0007568 | aging | 3.51e-01 | 1.00e+00 | 1.219 | 1 | 2 | 123 |
GO:0006260 | DNA replication | 3.55e-01 | 1.00e+00 | 1.196 | 1 | 4 | 125 |
GO:0006805 | xenobiotic metabolic process | 3.64e-01 | 1.00e+00 | 1.150 | 1 | 1 | 129 |
GO:0030027 | lamellipodium | 3.67e-01 | 1.00e+00 | 1.139 | 1 | 1 | 130 |
GO:0008285 | negative regulation of cell proliferation | 3.68e-01 | 1.00e+00 | 0.642 | 2 | 4 | 367 |
GO:0016477 | cell migration | 3.69e-01 | 1.00e+00 | 1.128 | 1 | 2 | 131 |
GO:0046983 | protein dimerization activity | 3.69e-01 | 1.00e+00 | 1.128 | 1 | 1 | 131 |
GO:0031982 | vesicle | 3.75e-01 | 1.00e+00 | 1.095 | 1 | 2 | 134 |
GO:0044255 | cellular lipid metabolic process | 3.89e-01 | 1.00e+00 | 1.032 | 1 | 1 | 140 |
GO:0045202 | synapse | 3.89e-01 | 1.00e+00 | 1.032 | 1 | 1 | 140 |
GO:0061024 | membrane organization | 4.01e-01 | 1.00e+00 | 0.972 | 1 | 1 | 146 |
GO:0010628 | positive regulation of gene expression | 4.08e-01 | 1.00e+00 | 0.942 | 1 | 2 | 149 |
GO:0006457 | protein folding | 4.08e-01 | 1.00e+00 | 0.942 | 1 | 1 | 149 |
GO:0046982 | protein heterodimerization activity | 4.08e-01 | 1.00e+00 | 0.521 | 2 | 3 | 399 |
GO:0007166 | cell surface receptor signaling pathway | 4.08e-01 | 1.00e+00 | 0.942 | 1 | 1 | 149 |
GO:0051260 | protein homooligomerization | 4.10e-01 | 1.00e+00 | 0.933 | 1 | 1 | 150 |
GO:0006508 | proteolysis | 4.21e-01 | 1.00e+00 | 0.482 | 2 | 2 | 410 |
GO:0007165 | signal transduction | 4.26e-01 | 1.00e+00 | 0.270 | 4 | 8 | 950 |
GO:0043005 | neuron projection | 4.32e-01 | 1.00e+00 | 0.831 | 1 | 4 | 161 |
GO:0043066 | negative regulation of apoptotic process | 4.49e-01 | 1.00e+00 | 0.403 | 2 | 5 | 433 |
GO:0007420 | brain development | 4.54e-01 | 1.00e+00 | 0.735 | 1 | 1 | 172 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.63e-01 | 1.00e+00 | 0.694 | 1 | 3 | 177 |
GO:0005667 | transcription factor complex | 4.65e-01 | 1.00e+00 | 0.686 | 1 | 3 | 178 |
GO:0031625 | ubiquitin protein ligase binding | 4.69e-01 | 1.00e+00 | 0.670 | 1 | 2 | 180 |
GO:0019904 | protein domain specific binding | 4.71e-01 | 1.00e+00 | 0.662 | 1 | 2 | 181 |
GO:0001525 | angiogenesis | 5.05e-01 | 1.00e+00 | 0.518 | 1 | 1 | 200 |
GO:0003924 | GTPase activity | 5.11e-01 | 1.00e+00 | 0.496 | 1 | 2 | 203 |
GO:0030168 | platelet activation | 5.14e-01 | 1.00e+00 | 0.482 | 1 | 1 | 205 |
GO:0070062 | extracellular vesicular exosome | 5.25e-01 | 1.00e+00 | 0.035 | 9 | 15 | 2516 |
GO:0006184 | GTP catabolic process | 5.39e-01 | 1.00e+00 | 0.380 | 1 | 2 | 220 |
GO:0005759 | mitochondrial matrix | 5.60e-01 | 1.00e+00 | 0.297 | 1 | 4 | 233 |
GO:0003713 | transcription coactivator activity | 5.69e-01 | 1.00e+00 | 0.261 | 1 | 7 | 239 |
GO:0030425 | dendrite | 5.71e-01 | 1.00e+00 | 0.255 | 1 | 1 | 240 |
GO:0007399 | nervous system development | 5.78e-01 | 1.00e+00 | 0.225 | 1 | 3 | 245 |
GO:0043025 | neuronal cell body | 5.92e-01 | 1.00e+00 | 0.173 | 1 | 3 | 254 |
GO:0005874 | microtubule | 5.97e-01 | 1.00e+00 | 0.150 | 1 | 3 | 258 |
GO:0003779 | actin binding | 6.21e-01 | 1.00e+00 | 0.058 | 1 | 1 | 275 |
GO:0045087 | innate immune response | 6.39e-01 | 1.00e+00 | -0.105 | 2 | 4 | 616 |
GO:0043234 | protein complex | 6.53e-01 | 1.00e+00 | -0.067 | 1 | 4 | 300 |
GO:0004674 | protein serine/threonine kinase activity | 6.68e-01 | 1.00e+00 | -0.124 | 1 | 2 | 312 |
GO:0044281 | small molecule metabolic process | 6.73e-01 | 1.00e+00 | -0.177 | 4 | 12 | 1295 |
GO:0035556 | intracellular signal transduction | 6.74e-01 | 1.00e+00 | -0.147 | 1 | 2 | 317 |
GO:0019901 | protein kinase binding | 6.77e-01 | 1.00e+00 | -0.160 | 1 | 4 | 320 |
GO:0005575 | cellular_component | 6.79e-01 | 1.00e+00 | -0.169 | 1 | 1 | 322 |
GO:0030154 | cell differentiation | 6.83e-01 | 1.00e+00 | -0.183 | 1 | 2 | 325 |
GO:0008283 | cell proliferation | 6.90e-01 | 1.00e+00 | -0.209 | 1 | 3 | 331 |
GO:0043231 | intracellular membrane-bounded organelle | 6.91e-01 | 1.00e+00 | -0.213 | 1 | 1 | 332 |
GO:0015031 | protein transport | 7.17e-01 | 1.00e+00 | -0.318 | 1 | 2 | 357 |
GO:0005925 | focal adhesion | 7.30e-01 | 1.00e+00 | -0.370 | 1 | 2 | 370 |
GO:0007155 | cell adhesion | 7.43e-01 | 1.00e+00 | -0.423 | 1 | 2 | 384 |
GO:0009986 | cell surface | 7.76e-01 | 1.00e+00 | -0.560 | 1 | 4 | 422 |
GO:0007596 | blood coagulation | 8.07e-01 | 1.00e+00 | -0.696 | 1 | 1 | 464 |
GO:0055114 | oxidation-reduction process | 8.19e-01 | 1.00e+00 | -0.748 | 1 | 2 | 481 |
GO:0003674 | molecular_function | 8.45e-01 | 1.00e+00 | -0.872 | 1 | 1 | 524 |
GO:0005615 | extracellular space | 8.76e-01 | 1.00e+00 | -0.819 | 2 | 4 | 1010 |
GO:0005783 | endoplasmic reticulum | 8.86e-01 | 1.00e+00 | -1.091 | 1 | 2 | 610 |
GO:0046872 | metal ion binding | 8.96e-01 | 1.00e+00 | -0.770 | 3 | 6 | 1465 |
GO:0005794 | Golgi apparatus | 9.02e-01 | 1.00e+00 | -1.183 | 1 | 1 | 650 |
GO:0005886 | plasma membrane | 9.46e-01 | 1.00e+00 | -0.722 | 6 | 14 | 2834 |
GO:0005887 | integral component of plasma membrane | 9.69e-01 | 1.00e+00 | -1.747 | 1 | 1 | 961 |
GO:0016021 | integral component of membrane | 9.95e-01 | 1.00e+00 | -1.531 | 3 | 7 | 2483 |